Annual EBIT
-$7.51 M
+$9.59 M+56.06%
December 31, 2023
Summary
- As of February 7, 2025, CLGN annual earnings before interest & taxes is -$7.51 million, with the most recent change of +$9.59 million (+56.06%) on December 31, 2023.
- During the last 3 years, CLGN annual EBIT has fallen by -$1.91 million (-34.17%).
- CLGN annual EBIT is now -11656.92% below its all-time high of $65.00 thousand, reached on December 31, 2021.
Performance
CLGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$4.54 M
-$136.00 K-3.09%
September 30, 2024
Summary
- As of February 7, 2025, CLGN quarterly earnings before interest & taxes is -$4.54 million, with the most recent change of -$136.00 thousand (-3.09%) on September 30, 2024.
- Over the past year, CLGN quarterly EBIT has increased by +$60.00 thousand (+1.30%).
- CLGN quarterly EBIT is now -145.30% below its all-time high of $10.03 million, reached on March 1, 2021.
Performance
CLGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$18.34 M
+$60.00 K+0.33%
September 30, 2024
Summary
- As of February 7, 2025, CLGN TTM earnings before interest & taxes is -$18.34 million, with the most recent change of +$60.00 thousand (+0.33%) on September 30, 2024.
- Over the past year, CLGN TTM EBIT has dropped by -$11.22 million (-157.65%).
- CLGN TTM EBIT is now -404.08% below its all-time high of $6.03 million, reached on March 1, 2021.
Performance
CLGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CLGN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.1% | +1.3% | -157.7% |
| 3 y3 years | -34.2% | +1.3% | -157.7% |
| 5 y5 years | -77.0% | +1.3% | -157.7% |
CLGN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | +56.1% | -180.0% | +10.4% | <-9999.0% | +0.3% |
| 5 y | 5-year | <-9999.0% | +56.1% | -145.3% | +10.4% | -404.1% | +0.3% |
| alltime | all time | <-9999.0% | +56.1% | -145.3% | +10.4% | -404.1% | +0.3% |
CollPlant Biotechnologies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.54 M(+3.1%) | -$18.34 M(-0.3%) |
| Jun 2024 | - | -$4.41 M(+1.8%) | -$18.41 M(+121.2%) |
| Mar 2024 | - | -$4.33 M(-14.6%) | -$8.32 M(+10.8%) |
| Dec 2023 | -$7.51 M(-56.1%) | -$5.07 M(+10.1%) | -$7.51 M(+5.5%) |
| Sep 2023 | - | -$4.60 M(-181.1%) | -$7.12 M(+1.9%) |
| Jun 2023 | - | $5.68 M(-261.3%) | -$6.99 M(-58.5%) |
| Mar 2023 | - | -$3.52 M(-24.7%) | -$16.85 M(-1.5%) |
| Dec 2022 | -$17.10 M(<-9900.0%) | -$4.68 M(+4.7%) | -$17.10 M(+5.4%) |
| Sep 2022 | - | -$4.47 M(+6.8%) | -$16.23 M(+9.3%) |
| Jun 2022 | - | -$4.18 M(+11.1%) | -$14.85 M(+8.2%) |
| Mar 2022 | - | -$3.77 M(-0.9%) | -$13.73 M(<-9900.0%) |
| Dec 2021 | $65.00 K(-101.2%) | - | - |
| Dec 2021 | - | -$3.80 M(+22.9%) | $65.00 K(-94.3%) |
| Sep 2021 | - | -$3.09 M(+1.0%) | $1.13 M(-77.1%) |
| Jun 2021 | - | -$3.06 M(-130.6%) | $4.94 M(-18.1%) |
| Mar 2021 | - | $10.03 M(-466.2%) | $6.03 M(-207.9%) |
| Dec 2020 | -$5.60 M(-26.6%) | - | - |
| Dec 2020 | - | -$2.74 M(-483.5%) | -$5.59 M(+8.2%) |
| Sep 2020 | - | $714.00 K(-136.3%) | -$5.17 M(-32.6%) |
| Jun 2020 | - | -$1.97 M(+23.3%) | -$7.67 M(+10.5%) |
| Mar 2020 | - | -$1.60 M(-31.0%) | -$6.94 M(-0.9%) |
| Dec 2019 | -$7.63 M(+79.8%) | - | - |
| Dec 2019 | - | -$2.31 M(+29.6%) | -$7.00 M(+73.2%) |
| Sep 2019 | - | -$1.79 M(+43.8%) | -$4.04 M(+13.2%) |
| Jun 2019 | - | -$1.24 M(-25.1%) | -$3.57 M(-1.7%) |
| Mar 2019 | - | -$1.66 M | -$3.63 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$4.25 M(-28.7%) | - | - |
| Dec 2018 | - | $644.00 K(-149.0%) | -$3.95 M(-38.5%) |
| Sep 2018 | - | -$1.31 M(+1.0%) | -$6.42 M(+4.1%) |
| Jun 2018 | - | -$1.30 M(-34.0%) | -$6.17 M(-5.1%) |
| Mar 2018 | - | -$1.97 M(+7.8%) | -$6.50 M(+9.4%) |
| Dec 2017 | -$5.96 M(-16.8%) | - | - |
| Dec 2017 | - | -$1.83 M(+72.7%) | -$5.94 M(+2.5%) |
| Sep 2017 | - | -$1.06 M(-34.9%) | -$5.79 M(-11.3%) |
| Jun 2017 | - | -$1.63 M(+15.1%) | -$6.53 M(-0.4%) |
| Mar 2017 | - | -$1.42 M(-16.0%) | -$6.55 M(-7.8%) |
| Dec 2016 | -$7.16 M(+48.6%) | - | - |
| Dec 2016 | - | -$1.69 M(-6.1%) | -$7.10 M(-2.5%) |
| Sep 2016 | - | -$1.80 M(+8.6%) | -$7.28 M(+9.9%) |
| Jun 2016 | - | -$1.65 M(-15.9%) | -$6.63 M(+11.5%) |
| Mar 2016 | - | -$1.97 M(+5.3%) | -$5.95 M(+22.6%) |
| Dec 2015 | -$4.82 M(+37.6%) | - | - |
| Dec 2015 | - | -$1.87 M(+63.6%) | -$4.85 M(+23.2%) |
| Sep 2015 | - | -$1.14 M(+17.6%) | -$3.94 M(+12.0%) |
| Jun 2015 | - | -$970.40 K(+11.4%) | -$3.52 M(+3.4%) |
| Mar 2015 | - | -$871.40 K(-8.8%) | -$3.40 M(+34.4%) |
| Dec 2014 | -$3.50 M(-25.8%) | - | - |
| Dec 2014 | - | -$955.40 K(+32.9%) | -$2.53 M(+60.7%) |
| Sep 2014 | - | -$719.00 K(-16.0%) | -$1.57 M(+84.0%) |
| Jun 2014 | - | -$855.90 K | -$855.90 K |
| Dec 2013 | -$4.72 M(+2.9%) | - | - |
| Dec 2012 | -$4.59 M | - | - |
FAQ
- What is CollPlant Biotechnologies annual earnings before interest & taxes?
- What is the all time high annual EBIT for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies annual EBIT year-on-year change?
- What is CollPlant Biotechnologies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies quarterly EBIT year-on-year change?
- What is CollPlant Biotechnologies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies TTM EBIT year-on-year change?
What is CollPlant Biotechnologies annual earnings before interest & taxes?
The current annual EBIT of CLGN is -$7.51 M
What is the all time high annual EBIT for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high annual earnings before interest & taxes is $65.00 K
What is CollPlant Biotechnologies annual EBIT year-on-year change?
Over the past year, CLGN annual earnings before interest & taxes has changed by +$9.59 M (+56.06%)
What is CollPlant Biotechnologies quarterly earnings before interest & taxes?
The current quarterly EBIT of CLGN is -$4.54 M
What is the all time high quarterly EBIT for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high quarterly earnings before interest & taxes is $10.03 M
What is CollPlant Biotechnologies quarterly EBIT year-on-year change?
Over the past year, CLGN quarterly earnings before interest & taxes has changed by +$60.00 K (+1.30%)
What is CollPlant Biotechnologies TTM earnings before interest & taxes?
The current TTM EBIT of CLGN is -$18.34 M
What is the all time high TTM EBIT for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high TTM earnings before interest & taxes is $6.03 M
What is CollPlant Biotechnologies TTM EBIT year-on-year change?
Over the past year, CLGN TTM earnings before interest & taxes has changed by -$11.22 M (-157.65%)